Polypharmacy and mobility outcomes.
Chronic disease
Mobility
Multi-morbidity
Older adults
Polypharmacy
Journal
Mechanisms of ageing and development
ISSN: 1872-6216
Titre abrégé: Mech Ageing Dev
Pays: Ireland
ID NLM: 0347227
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
20
01
2020
revised:
02
09
2020
accepted:
07
09
2020
pubmed:
30
9
2020
medline:
29
10
2021
entrez:
29
9
2020
Statut:
ppublish
Résumé
Polypharmacy is known to be associated with negative consequences of mobility related conditions such as falls, functional decline and disability. This systematic review highlights the effectiveness of deprescribing interventions on mobility related conditions in older adults in the community dwelling reported taking five or more medications daily.
Identifiants
pubmed: 32991919
pii: S0047-6374(20)30152-4
doi: 10.1016/j.mad.2020.111356
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
111356Subventions
Organisme : CIHR
ID : PJT 148971
Pays : Canada
Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.